Öznur Özge Özcan

Dr. Öznur Özge Özcan

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2020 in AIMS Biophysics
Verified
Journal Article
Open access
PDF file
SEZER OKAYSEZER OKAY
SEZER OKAY
ÖÖÖznur Özge Özcan
Öznur Özge Özcan
MKMesut Karahan
Mesut Karahan
Conventional vaccines have saved millions of lives, and new vaccines have also been developed; however, an urgent need for an efficient vaccine against SARS-CoV-2 showed us that vaccine development technologies should be improved more to obtain prophylactic agents rapidly during pandemic diseases. One of the next-generation vaccine technologies is utilization of mRNA molecules encoding antigens. The mRNA vaccines offer many advantages compared to conventional and other subunit vaccines. For instance, mRNA vaccines are relatively safe since they do not cause disease and mRNA does not integrate into the genome. mRNA vaccines also provide diverse types of immune responses resulting in the activation of CD4+ and CD8+ T cells. However, utilization of mRNA molecules also has some drawbacks such as degradation by ubiquitous nucleases in vivo. Nanoparticles (NPs) are delivery platforms that carry the desired molecule, a drug or a vaccine agent, to the target cell such as antigen presenting cells in the case of vaccine development. NP platforms also protect mRNA molecules from the degradation by nucleases. Therefore, efficient mRNA vaccines can be obtained via utilization of NPs in the formulation. Although lipid-based NPs are widely preferred in vaccine development due to the nature of cell membrane, there are various types of other NPs used in vaccine formulations, such as virus-like particles (VLPs), polymers, polypeptides, dendrimers or gold NPs. Improvements in the NP delivery technologies will contribute to the development of mRNA vaccines with higher efficiency.

3 July 2022 in International Journal of Neuroscience
Verified
Journal Article
Closed access
RKRümeysa Rabia Kocatürk
Rümeysa Rabia Kocatürk
ATArzu Temizyürek
Arzu Temizyürek
ÖÖÖznur Özge Özcan
Öznur Özge Özcan
TETürker Tekin Ergüzel
Türker Tekin Ergüzel
MKMesut Karahan
Mesut Karahan
NTNevzat Tarhan
Nevzat Tarhan
Aim: To summarize the nutritional supplementation on biochemical parameters, cognition, function, Alzheimer's Disease (AD) biomarkers and nutritional status. Materials and methods: PubMed, Web of Science, Korean Journal Database, Russian Science Citation Index, SciELO Citation Index, Cochrane Library and Scopus databases were searched until 16 April 2021. 22.193 records in total were reached according to inclusion and exclusion criteria. Included Studies were evaluated through the Modified Jadad Scale and gathered under four subheadings. Results: 48 studies with a total of 7009 AD patients were included. Souvenaid, ONS (368 ± 69 kcal), Vegenat-med, 500 mg Resveratrol, ONS (200 mL) were effective nutritional supplements on promoting weight gain and protecting malnutrition status but showed conflicting results in Body mass index, Mid-Upper-Arm Circumference and Triceps Skin Fold Thickness. ONS and a lyophilized whole supplementation Vegenat-med intake made an increase in MNA scores. While all nutritional supplements showed controversial results in biochemical parameters but caused a decrease in Hcy levels which caused reductions in brain Aβ plaque (increase serum Aβ), p-Tau and cognitive improvement. Folic acid and vitamin D decreased serum APP, BACE1, BACE1mRNA. Resveratrol, Hericium erinaceus mycelia, vitamin D and Betaine supplements improved cognitive, functional prognosis and quality of life unlike other nutritional supplements had no effect on cognitive scales. Conclusions: Better designed trials with holistic measures are needed to investigate the effect of nutritional support on the AD biomarkers, cognitive status, biochemical parameters and functional states. Also, more beneficial results can be obtained by examining the simultaneous effects of nutritional supplements with larger sample groups.

30 September 2022 in Baltic Journal of Health and Physical Activity
Verified
Journal Article
Closed access
PDF file
RKRabia Rümeysa Kocatürk
Rabia Rümeysa Kocatürk
IKİlke Karagöz
İlke Karagöz
EYEbru Yanik
Ebru Yanik
ÖÖÖznur Özge Özcan
Öznur Özge Özcan
TETürker Tekin Ergüzel
Türker Tekin Ergüzel
NTNevzat Tarhan
Nevzat Tarhan
Introduction: This systematic review aims to examine the effects of the CYP1A2 −163C>A and ADORA2A 1976T>C polymorphism on physiological effects and performance relative to caffeine consumption. Material and Methods: In this study, electronic databases including PubMed, Web of Science Core Collection, Korean Journal Database, Russian Science Citation Index, SciELO Citation Index, Scopus, ScienceDirect, ProQuest Dissertations & Thesis Global and EBSCO were searched. Results: The results highlight that individuals with the TT or CT/CC genotype can have differences in caffeine consumption, and C carriers may have increases in the maximum oxygen uptake (VO2max). The AA or AC/CC genotypes can have different caffeine consumption and VO2max. In four studies, TT or CT/CC either in AA or CC genotype had different physiological effects. Regardless of the amount of caffeine (3 mg/kg-5 mg/kg), Carriers of the C allele in the genotype ADORA2A gene have higher sports performance. Six studies revealed a significant correlation between the AA genotype and performance following caffeine intake. Conclusions: Genotype variations in ADORA2A and CYP1A2 may modulate the ergogenic effects of caffeine, but some physiological effects can occur for different genotypes.

1 March 2024 in Basic and Clinical Neuroscience Journal
Verified
Journal Article
Open access
PDF file
EAElif Sina Atak
Elif Sina Atak
DYDilara Yıldız
Dilara Yıldız
RKRümeysa Rabia Kocatürk
Rümeysa Rabia Kocatürk
ATArzu Temizyürek
Arzu Temizyürek
ÖÖÖznur Özge Özcan
Öznur Özge Özcan
NTNevzat Tarhan
Nevzat Tarhan
Introduction: Parkinson disease is the world’s second most prevalent neurological disease. In this disease, intracytoplasmic neuronal inclusions are observed in enteric neurons in the gastrointestinal tract, and the composition of the intestinal microbiome is altered. These changes correlate with the motor phenotype. A systematic review was conducted to determine the effect of using probiotics in Parkinson disease. Methods: Scopus, PubMed, Web of Science, the Cochrane Library, ScienceDirect, and Ovıd-LWW were searched until April 2021. A total of 27395 records were found according to inclusion and exclusion criteria with the following outcomes: Parkinson disease rating, oxidative stress, and gastrointestinal system markers. Data search, article selection, and data extraction assessments were performed according to the PRISMA (preferred reporting items for systematic reviews and meta-analyses) guidelines. The Jadad scale was used to rate the evidence’s quality. Results: Our study information was gathered from 5 randomized controlled trials involving 350 individuals with Parkinson disease receiving probiotic supplements. Parkinson disease rating and non-motor symptoms test were performed in the samples. Also, oxidative stress (glutathione, malondialdehyde) and gastrointestinal system symptoms (bowel opening frequency, gut transit time, complete bowel movement, spontaneous bowel movements) were evaluated during 4-12 weeks of using probiotics in these patients. Conclusion: While all high-quality studies demonstrate improvement in disease symptoms of the patients, currently sufficient data are not available to recommend the use of probiotics for people with Parkinson disease in clinical practice.

3 November 2025 in BMC Psychology
Verified
Journal Article
Open access
PDF file
ÖÖÖznur Özge Özcan
Öznur Özge Özcan
BÇBurcu Çevreli
Burcu Çevreli
Eating disorder (ED) symptoms are particularly prevalent among young adults. This study aimed to examine the distinct roles of memory function, mental health, and sleep disturbances in university students with different ED diagnostic categories. In this cross-sectional study, 403 female students were allocated to anorexia nervosa (AN, n = 90), bulimia nervosa (BN, n = 53), binge-eating disorder (BED, n = 116), or healthy controls (HCG, n = 144) based on self-reported physician diagnoses consistent with DSM-5 categories. Participants completed the Eating Disorder Examination-Questionnaire (EDE-Q), Memory Functioning Questionnaire (MFQ), Bergen Insomnia Scale (BIS), and Depression Anxiety Stress Scales – 21 (DASS-21) in a single time-point assessment (January and May 2025). Participants in the AN and BN groups showed significantly higher levels of depression, anxiety, stress, insomnia, and ED pathology, along with memory dysfunction, compared to the BED and HCG groups (p < 0.001). Depression scores were markedly elevated in AN (mean = 13.8, 95% CI [6.5–8.8]) and BN (mean = 19.2, 95% CI [12.1–14.1]) relative to HCG (mean = 6.1) and BED (mean = 9.7). Similarly, insomnia scores were higher in BN (mean = 35.2, 95% CI [25.1–27.7]) and AN (mean = 26.6, 95% CI [15.5–19.9]) compared to BED (mean = 11.3) and HCG (mean = 8.9). Within-group analyses further revealed that in AN, anxiety, stress, forgetfulness, and weight/appearance concerns were strongly interrelated (p < 0.05), while in BN, insomnia, affective symptoms, and memory dysfunction were tightly linked with overall ED severity (p < 0.05). In the BED group, binge eating behaviors showed significant associations with insomnia, affective symptoms, and cognitive difficulties (p < 0.05). ED groups—particularly BN and AN—are characterized by co-occurring insomnia, affective symptoms, and poorer perceived memory functioning. Findings support integrated assessments that include sleep and cognition alongside ED psychopathology and may inform individualized interventions. Results should be interpreted cautiously given reliance on self-reported diagnoses and a single-site, female-only sample.

25 January 2025 in Euchembioj Reviews
Verified
Journal Article
Open access
PDF file
ÖÖÖznur Özge Özcan
Öznur Özge Özcan
BCBurcu Cevreli
Burcu Cevreli
MKMesut Karahan
Mesut Karahan
ÜUÜsküdar University
Üsküdar University
The most characteristic symptoms for the diagnosis of autism spectrum disorder (ASD) and the future life of the individual are deterioration in social communication and stereotyped or repetitive behaviors. ASD is associated with diverse atypical difficulties, including memory, learning, language, emotion, and cognitive impairment. Consequently, the hippocampus is important for memory, learning, language ability, emotional regulation, and cognitive mapping. Thus, the hippocampus plays an influential role in the pathophysiological mechanisms of ASD. Here, we provide an updated review of hippocampal structural and functional abnormalities and highlight the hippocampus as an important area for future research.